(Ph.No.326077) Aso Latex Agglutination Assay to Detect Anti Streptolysin O Antibody... Tender

SOUTH CENTRAL RAILWAY has floated a tender for (Ph.No.326077) Aso Latex Agglutination Assay to Detect Anti Streptolysin O Antibody in Patient's Samples, Unit: Numbers.. The project location is Hyderabad, Telangana, India. The reference number is SCRLGD2432607730141 and it is closing on 26 Jun 2024. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Expired Tender

Procurement Summary

State : Telangana

Summary : (Ph.No.326077) Aso Latex Agglutination Assay to Detect Anti Streptolysin O Antibody in Patient's Samples, Unit: Numbers.

Deadline : 26 Jun 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 101463630

Document Ref. No. : SCRLGD2432607730141

Competition : NCB

Financier : Self Financed

Purchaser Ownership : Public

Document Fees : Refer Document

Tender Value : Refer Document

EMD : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

(PH.No.326077) ASO LATEX AGGLUTINATION ASSAY TO DETECT ANTI STREPTOLYSIN O ANTIBODY IN PATIENT'S SAMPLES, UNIT: NUMBERS. [ Warranty Period: 30 Months after the date of delive ry ]
Contract Category: Expenditure
Contract Type : Goods
Tender Type : Limited - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : MEDICAL
Inspection Agency : CONSIGNEE
Publishing Date / Time : 20/05/2024 09:49
Procure From Approved Sources : No
Approving Agency : Not Applicable
Closing Date Time : 26/06/2024 10:30
Validity of Offer ( Days) : 90
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00

Consignee MD/CH/LGD Telangana 300.00 Numbers

Documents

 Tender Notice

viewNitPdf_4576667.pdf

DrugProcurementPolicy2014.pdf